查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446969

到 2030 年高壓顯影劑注射器的全球市場預測：按產品類型、應用、最終用戶和地區進行分析

High Pressure Contrast Media Injector Market Forecasts to 2030 - Global Analysis By Product (Injector Systems and Consumables), Type (Single Head Injectors, Syringeless Injectors and Dual Head Injectors), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

據Stratistics MRC稱，2023年全球高壓顯影劑注射器市場規模將達到1.776億美元，預計到2030年將達到4.472億美元，預測期內年複合成長率為14.1%。

高壓顯影劑是用於放射學和成像程序的醫療設備，特別是電腦斷層掃描 (CT) 掃描和血管造影術。該裝置通常由含有顯影劑的注射器或儲液器、高壓注射器系統和電腦控制面板組成。這些注射器以受控的速率和壓力輸送顯影劑，確保在整個脈管系統中一致且均勻的分佈。其結果是提高了血管、器官和組織的可見度，從而產生更清晰、更詳細的影像。

根據世界衛生組織（WHO）的估計，癌症是世界上大多數國家的主要原因之一。

微創手術需求不斷成長

微創手術技術因其與傳統開放性手術相比的潛在優勢而越來越受歡迎。隨著微創手術在各個醫療領域變得普及普遍，在這些手術過程中對高品質影像導引的需求變得至關重要。此外，高壓顯影劑輸液設備在血管內治療、介入放射學和腹腔鏡手術等微創手術中的血管、器官和組織的即時可視化中發揮重要作用。

不利事件的風險

高壓顯影劑注射器是一種將顯影劑直接注入患者血液的醫療設備。因此，存在與顯影劑給藥相關的不利事件的風險，例如過敏反應、血管外浸潤和過敏反應。此外，顯影劑腎臟病是一種潛在的併發症，其特徵是顯影劑暴露後的急性腎損傷，尤其是有腎功能不全病史的患者。不利事件的發生可能會導致患者受傷、醫療成本增加以及醫療保健提供者和設施的責任風險。這些因素限制了市場的擴張。

成像技術的進步

隨著成像技術的發展並變得更加複雜，對造影增強成像程序以提供詳細且準確的診斷資訊的需求日益增加。高壓顯影劑注射器是造影劑增強成像程序的重要組成部分，因為它們可以以精確且受控的方式可靠地將顯影劑顯影劑輸送到患者的血流中。此外，以高壓和受控速率注射顯影劑顯影劑最佳化其在整個脈管系統中的分佈，從而可以清晰地顯示解剖結構和異常情況。因此，影像處理技術的進步已成為市場擴張的主要因素。

與替代顯像模式的衝突

超音波、磁振造影(MRI) 和光同調斷層掃瞄(OCT) 等方式可提供詳細的解剖和功能資訊，而無需注射造影顯影劑。這些替代成像方式比顯影劑增強成像方式具有優勢，包括降低副作用風險和避免電離輻射暴露。因此，醫療保健提供者可能會擴大選擇替代成像方式而不是顯影劑注射技術，從而可能減少對高壓顯影劑注射器的需求。

COVID-19 的影響

COVID-19 大流行對高壓顯影劑劑注射器市場產生了負面影響。世界各地的醫療保健系統因 COVID-19 患者的湧入而不堪重負，導致包括診斷成像在內的非緊急醫療程序被推遲或取消，並且對顯影劑的需求減少。此外，許多醫院和診斷影像中心也面臨人員短缺、供應鏈中斷和財務限制等營運挑戰。

預計消耗品領域在預測期內將是最大的

消耗品部分估計佔最大佔有率。耗材在支援顯影劑注射系統的操作和功能方面發揮關鍵作用。注射器是一種重要的消耗品，用於容納顯影劑並將其輸送到注射系統。此外，它們具有多種尺寸和配置，以適應不同的注射量和流速。因此，對耗材的需求是一致的，並且與臨床中高壓顯影劑的使用密切相關。

預計單頭注射器細分市場在預測期內年複合成長率最高

預計單頭注射器細分市場在預測期內將出現良好的成長。這些注射器旨在透過單一注射頭或注射器以受控的速率和壓力將顯影劑輸送到患者的血流中。此外，這些注射器簡單易用，適合醫療保健環境中的常規影像處理。這些注射器旨在以最小的變化提供精確數量的顯影劑，確保影像檢查中一致的影像品質和診斷準確性。

佔比最高的地區

憑藉先進的醫療基礎設施、技術創新和診斷成像的高需求，北美在預測期內佔據了最大的市場佔有率。該地區包括美國、加拿大和墨西哥，擁有大量醫療支出，並專注於醫療進步和患者護理。此外，北美的技術進步和研發工作正在促進高壓顯影劑技術的持續發展。

年複合成長率最高的地區：

預計歐洲在預測期內將出現盈利成長。歐洲醫療保健基礎設施的特點是擁有完善的醫院、診斷影像中心和學術機構，提供最先進的診斷影像程序。此外，該地區也是幾家主要醫療設備製造商的所在地，其中包括高壓顯影劑注射器。這些公司利用該地區強大的研發能力、監管專業知識和品質標準來開發創新注射器技術，以滿足醫療保健專業人員和患者的需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球高壓顯影劑注射器市場：按產品

  • 注射器系統
  • 消耗品
    • 管子
    • 注射器

第6章全球高壓顯影劑注射器市場：按類型

  • 單頭注射器
  • 無注射器注射器
  • 雙頭注射器

第7章全球高壓顯影劑注射器市場：依應用分類

  • 介入放射學
  • 血管內手術
  • 介入性心臟病學
  • 其他用途

第8章全球高壓顯影劑注射器市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 診斷中心

第9章全球高壓顯影劑注射器市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Guerbet Group
  • Bayers Healthcare LLC
  • Bracco Group
  • Ulrich GmbH & Co. KG
  • Medtron AG
  • GE Healthcare
  • NemotoKyorindo Co. Ltd
  • Apollo RT Co. Ltd
  • Vivid Imaging
  • Sino Medical Device Technology Co.
Product Code: SMRC25230

According to Stratistics MRC, the Global High Pressure Contrast Media Injector Market is accounted for $177.6 million in 2023 and is expected to reach $447.2 million by 2030 growing at a CAGR of 14.1% during the forecast period. A high-pressure contrast media injector is a medical device used in radiology and diagnostic imaging procedures, particularly computed tomography (CT) scans and angiography. The device typically consists of a syringe or reservoir containing the contrast media, a high-pressure injector system, and a computerized control panel. These injectors deliver contrast media at a controlled rate and pressure, ensuring consistent and uniform distribution throughout the vascular system. This results in improved visualization of blood vessels, organs, and tissues, leading to clearer and more detailed images.

According to the World Health Organization (WHO) estimates, cancer is the one of the leading causes of death in majority of countries globally.

Market Dynamics:

Driver:

Rising demand for minimally invasive surgeries

Minimally invasive surgical techniques have gained popularity due to their potential benefits compared to traditional open surgeries. As minimally invasive procedures become more widespread across various medical specialties, the need for high-quality imaging guidance during these procedures becomes paramount. Additionally, high-pressure contrast media injectors play a crucial role in providing real-time visualization of blood vessels, organs, and tissues during minimally invasive surgeries, such as endovascular procedures, interventional radiology, and laparoscopic surgeries.

Restraint:

Risk of adverse events

High-pressure contrast media injectors are medical devices that administer contrast agents directly into the patient's bloodstream. As such, there is a risk of adverse events associated with contrast administration, such as allergic reactions, extravasation, and anaphylaxis. Furthermore, contrast-induced nephropathy is a potential complication characterized by acute kidney injury following contrast media exposure, particularly in patients with pre-existing renal impairment. The occurrence of adverse events can result in patient harm, increased healthcare costs, and liability risks for healthcare providers and facilities. These factors limit the market's expansion.

Opportunity:

Advancements in imaging technologies

As imaging technologies evolve and become more sophisticated, there is a growing need for contrast-enhanced imaging procedures to provide detailed and accurate diagnostic information. High-pressure contrast media injectors are essential components in contrast-enhanced imaging procedures, as they ensure the precise and controlled delivery of contrast agents into the patient's bloodstream. Moreover, by delivering contrast media at high pressures and controlled rates, these injectors optimize the distribution of contrast agents throughout the vascular system, enabling clearer visualization of anatomical structures and abnormalities. As a result, advancements in imaging technologies are a significant factor propelling market expansion.

Threat:

Competition from alternative imaging modalities

Modalities such as ultrasound, magnetic resonance imaging (MRI), and optical coherence tomography (OCT) provide detailed anatomical and functional information without the need for Injectable contrast media. These alternative imaging modalities offer advantages over contrast-enhanced imaging techniques, including reduced risk of adverse reactions and avoidance of ionizing radiation exposure. As a result, healthcare providers may increasingly opt for alternative imaging modalities over contrast-enhanced techniques, leading to a decline in demand for high-pressure contrast media injectors.

Covid-19 Impact

The COVID-19 pandemic had negatively impacted the high-pressure contrast media injector market. With healthcare systems worldwide overwhelmed by the influx of COVID-19 patients, non-urgent medical procedures, including diagnostic imaging, have been postponed or cancelled, leading to a decline in demand for contrast media injectors. Moreover, many hospitals and imaging centers faced operational challenges, such as staffing shortages, supply chain disruptions, and financial constraints.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share. Consumables play a crucial role in supporting the operation and functionality of contrast media injection systems. Syringes are essential consumables that hold and deliver the contrast media to the injector system. Moreover, they come in various sizes and configurations to accommodate different injection volumes and flow rates. As a result, demand for consumables remains consistent and is closely related to the use of high-pressure contrast media injectors in clinical practice.

The single head injectors segment is expected to have the highest CAGR during the forecast period

The single head injectors segment is anticipated to have lucrative growth during the forecast period. These injectors are designed to deliver contrast media into the patient's bloodstream at a controlled rate and pressure through a single injection head or syringe. Furthermore, these injectors offer simplicity and ease of use, making them suitable for routine imaging procedures in healthcare settings. They are engineered to deliver precise volumes of contrast media with minimal variability, ensuring consistent image quality and diagnostic accuracy across imaging studies.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to its advanced healthcare infrastructure, technological innovation, and high demand for diagnostic imaging procedures. The region encompasses the United States, Canada, and Mexico, where healthcare expenditure is substantial and there is a strong emphasis on medical advancements and patient care. Moreover, technological advancements and research and development initiatives in North America contribute to the continuous evolution of high-pressure contrast media injector technologies.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe's healthcare infrastructure is characterized by well-established hospitals, imaging centers, and academic institutions, providing access to state-of-the-art diagnostic imaging procedures. Furthermore, the region is home to several leading manufacturers of medical devices, including high-pressure contrast media injectors. These companies leverage the region's strong research and development capabilities, regulatory expertise, and quality standards to develop innovative injector technologies that meet the needs of healthcare providers and patients.

Key players in the market

Some of the key players in the High Pressure Contrast Media Injector Market include Guerbet Group, Bayers Healthcare LLC, Bracco Group, Ulrich GmbH & Co. KG, Medtron AG, GE Healthcare, NemotoKyorindo Co. Ltd, Apollo RT Co. Ltd, Vivid Imaging and Sino Medical Device Technology Co.

Key Developments:

In September 2023, GE HealthCare and Mayo Clinic announced a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.

In December 2022, Bayer announced the U.S. launch of the Bayer Science Collaboration Explorer (BSCE) as part of its ongoing efforts to enhance public trust in scientific innovations, processes, and R&D activities.

In November 2022, GE Healthcare announced agreement with ulrich medical aimed at enhancing its market position in the growing U.S. market. As per the agreement, these two companies will co-ordinate to develop and offer multi-dose contrast media injector in the country.

In March 2022, Bracco Imaging and Philochem, a subsidiary of the Philogen Group collaborated on the development of a molecule for diagnostic applications

In December 2021, Bracco Imaging announced a global strategic collaboration agreement with Guerbet for Gadopiclenol, a high-relaxivity, macrocyclic contrast agent. Bracco Imaging and Guerbet will manufacture, as well as support research and development for future indications of Gadopiclenol, which the parties will commercialize independently under different brands.

Products Covered:

  • Injector Systems
  • Consumables

Types Covered:

  • Single Head Injectors
  • Syringeless Injectors
  • Dual Head Injectors

Applications Covered:

  • Interventional Radiology
  • Endovascular Surgery
  • Interventional Cardiology
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Diagnostic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Pressure Contrast Media Injector Market, By Product

  • 5.1 Introduction
  • 5.2 Injector Systems
  • 5.3 Consumables
    • 5.3.1 Tubing
    • 5.3.2 Syringes

6 Global High Pressure Contrast Media Injector Market, By Type

  • 6.1 Introduction
  • 6.2 Single Head Injectors
  • 6.3 Syringeless Injectors
  • 6.4 Dual Head Injectors

7 Global High Pressure Contrast Media Injector Market, By Application

  • 7.1 Introduction
  • 7.2 Interventional Radiology
  • 7.3 Endovascular Surgery
  • 7.4 Interventional Cardiology
  • 7.5 Other Applications

8 Global High Pressure Contrast Media Injector Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Diagnostic Centers

9 Global High Pressure Contrast Media Injector Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Guerbet Group
  • 11.2 Bayers Healthcare LLC
  • 11.3 Bracco Group
  • 11.4 Ulrich GmbH & Co. KG
  • 11.5 Medtron AG
  • 11.6 GE Healthcare
  • 11.7 NemotoKyorindo Co. Ltd
  • 11.8 Apollo RT Co. Ltd
  • 11.9 Vivid Imaging
  • 11.10 Sino Medical Device Technology Co.

List of Tables

  • Table 1 Global High Pressure Contrast Media Injector Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 4 Global High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 6 Global High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 7 Global High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 8 Global High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 9 Global High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 10 Global High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 11 Global High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 13 Global High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 14 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 15 Global High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 18 Global High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 19 Global High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 North America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 22 North America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 23 North America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 24 North America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 25 North America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 26 North America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 28 North America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 29 North America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 30 North America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 32 North America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 33 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 34 North America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 35 North America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 37 North America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 38 North America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 39 Europe High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 41 Europe High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 42 Europe High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 43 Europe High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 44 Europe High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 45 Europe High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 46 Europe High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 47 Europe High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 48 Europe High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 49 Europe High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 50 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 51 Europe High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 52 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 53 Europe High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 54 Europe High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 56 Europe High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 57 Europe High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 60 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 61 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 62 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 63 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 64 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 65 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 66 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 67 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 68 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 69 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 70 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 71 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 72 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 73 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 76 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 77 South America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 79 South America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 80 South America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 81 South America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 82 South America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 83 South America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 84 South America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 85 South America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 86 South America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 87 South America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 88 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 89 South America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 90 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 91 South America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 92 South America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 94 South America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 South America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 96 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 98 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 99 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 100 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 101 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 102 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 104 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 105 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 106 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 108 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 109 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 110 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 111 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 113 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 114 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)